Media Blatantly Misinforms the Public on COVID Vaccination
In a video post on the social media platform X on May 27, 2025, U.S. Secretary of Health and Human Services (HHS) Robert F. Kennedy, Jr. stated: The COVID vaccine for healthy children and healthy pregnant women has been removed from the CDC recommended immunization schedule. Last year, the Biden administration urged healthy children to […]
Autism Epidemic ‘Unprecedented in Human History,’ Now Reaches 1 in 31 Kids in America
On Apr. 15, 2025, the U.S. Centers for Disease Control and Prevention (CDC) published an analysis in its epidemiological digest Morbidity and Mortality Weekly Report (MMWR) which found the prevalence of autism spectrum disorder (ASD) among children eight years old in the United States to be 1 in 31 (3.2 percent).1 2 3 4 5 […]
FDA Approves Freeze-Dried Smallpox/Mpox Vaccine
On Mar. 31, 2025, the U.S. Food and Drug Administration (FDA) approved the freeze-dried formulation of Bavarian Nordic A/S’s Jynneos vaccine for smallpox and mpox (formerly monkey pox) in adults 18 years of age and older. The liquid-frozen formulation of the vaccine was approved by the FDA on Sept. 24, 2019, but that version requires […]
CDC Picks Thimerosal Researcher for Vaccines, Autism Study
On Mar. 7, 2025, the Associated Press and other media sources reported that the U.S. Centers for Disease Control and Prevention (CDC) is planning to conduct a study to determine possible links between vaccines and autism. In a prepared statement, the DHHS vaccine policymaking agency said that the “CDC will leave no stone unturned in its […]
Measles Outbreak in Texas
There has been a lot of media attention given lately to the measles outbreak in Texas. The outbreak now accounts for 90 cases—77 of them involving children under the age of 18. It has been reported that “most of those infected” either have not be vaccinated for measles or have an “unknown vaccination status,” while […]
BARDA’s Big Bird Flu Vax Contract With Moderna
Last month, Moderna, Inc. slashed its revenue forecast for this year by $1 billion, prompting its stock price to plunge by more than 20 percent to $33.44. In September 2024, Moderna estimated its revenue for 2025 would be $2.5 billion to $3.5 billion, but the company revised its forecast on Jan. 13, 2025 to $1.5 […]